Biodesign Discovery Series: Crossing Barriers in Alzheimer’s Drug Development

Date/Time
Date(s) - 10 Sep 2014 until 10 Sep 2014
10:00 AM - 11:00 AM

Location
The Biodesign Institute at ASU


Biodesign Events

 

Biodesign Discovery Series: Crossing Barriers in Alzheimer’s Drug Development

Wednesday, Sept. 10, 10 a.m.

Biodesign Institute, Auditorium B105, 727 E. Tyler St., Tempe, AZ 85287

 

 

Watts_flyer-interactive2-612x792pxV2

Dr. Ryan Watts, Director and Senior Scientist, Department of Neuroscience, Genentech

Ryan Watts leads 10 Genentech laboratories focused on developing therapies for Alzheimer’s and Parkinson’s diseases, ALS, pain and other neurological disorders. His research on the blood-brain barrier focuses on the ability of large molecules to transverse it. This effort has led to a new Alzheimer’s therapy and a pipeline of large molecule drugs focused on diseases affecting the central nervous system.

Can’t attend? Watch the seminar live via webcast or on-demand. More information